VETERANS AFFAIRS MED CTR SAN FRANCISCO
Validation of a novel drug target to treat RV failure
Validation of a novel drug target to treat RV failure is a funding opportunity from VETERANS AFFAIRS MED CTR SAN FRANCISCO, closing September 30, 2026.
Sep 30, 2026
(61d left)Overview
Right ventricular failure (RVF) is a serious clinical problem with a poor prognosis. RVF is the leading cause of death in patients with pulmonary hypertension. RVF has diverse causes including LV failure, primary cardiomyopathies, RV ischemia/infarction, pressure loading due to pulmonic stenosis or pulmonary…